GNVR Genvor Inc
Agricultural Production-Crops · OTC · SEC CIK 1792941 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY41.0%
TTM EPS YoY62.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-1,611.2%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets969.3%
Debt / equity—
Current ratio0.09x
Interest coverage-37.14x
Cash quality & payout
Operating cash flow / net income0.31x
Accruals ratio-1,119.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 | FY20222022-09-30 | FY20222021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | $0 |
| R&D expense | $455,901 | $240,263 | $0 | $0 | $226,448 |
| Operating income | -$6.41M | -$2.78M | -$1.44M | — | -$3.10M |
| Interest expense | $59,812 | $17,693 | $43,795 | — | $102,792 |
| Pretax income | -$5.59M | -$2.88M | -$1.71M | — | — |
| Income tax | — | — | — | — | $0 |
| Net income | -$5.59M | -$2.88M | -$1.71M | — | -$3.44M |
| EBITDA | -$6.41M | -$2.78M | -$1.44M | — | -$3.10M |
| EPS (basic) | — | -0.15 | -0.07 | — | -0.15 |
| EPS (diluted) | -0.22 | -0.15 | -0.07 | — | -0.15 |
| Weighted avg. shares (diluted) | 25.70M | 19.88M | 19.55M | — | 22.49M |
| Banking | |||||
| Net interest income | — | — | — | — | -$102,792 |
| Balance sheet | |||||
| Cash & equivalents | $37,231 | $373 | $44,354 | $296,386 | $384,621 |
| Current assets | $45,822 | $21,678 | $66,329 | $298,386 | $535,952 |
| PP&E, net | — | $13,902 | $15,734 | $17,565 | $18,939 |
| Total assets | $45,822 | $35,580 | $82,063 | $315,951 | $556,944 |
| Current liabilities | $1.36M | $1.75M | $1.79M | $1.62M | $2.45M |
| Long-term debt | $20,000 | $904,508 | $1.32M | $1.14M | — |
| Total debt | $20,000 | $904,508 | $1.32M | $1.14M | — |
| Total liabilities | $1.36M | $1.75M | $1.79M | $1.71M | $2.79M |
| Shareholders' equity | -$1.31M | -$1.71M | -$1.70M | -$1.39M | -$2.02M |
| Net debt | -$17,231 | $904,135 | $1.28M | $844,835 | — |
| Shares outstanding | 30.18M | 20.03M | 19.06M | 38.68M | 26.03M |
| Cash flow statement | |||||
| Operating cash flow | -$555,717 | -$975,641 | -$871,734 | — | -$663,203 |
| Financing cash flow | $592,575 | $931,660 | $619,702 | — | $899,851 |
| Depreciation & amortization | $1,376 | $1,832 | $1,832 | — | $1,832 |
| Stock-based compensation | $4.93M | $1.36M | $977,235 | — | $2.22M |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.